Notice

The database server is currently not answering requests properly. Some pages are still available due to caching. We are investigating the situation and will keep you updated.

State and Shandong Province Joint Key Laboratory of Translational Cardiovascular Medicine at Qilu Hospital, SDU
山东大学 齐鲁医院 国家和山东省联合转化心血管医学重点实验室

China

1 July 2019 - 30 June 2020

Principal institution: Qilu Hospital of Shandong University

Region: Global
Subject/journal group: All

The table to the right includes counts of all research outputs for State and Shandong Province Joint Key Laboratory of Translational Cardiovascular Medicine at Qilu Hospital, SDU published between 1 July 2019 - 30 June 2020 which are tracked by the Nature Index.

Hover over the donut graph to view the FC output for each subject. Below, the same research outputs are grouped by subject. Click on the subject to drill-down into a list of articles organized by journal, and then by title.

Note: Articles may be assigned to more than one subject area.

Count Share
3 0.44

Outputs by subject (Share)

Subject Count Share
Life Sciences 3 0.44

Top articles by Altmetric score in current window

Bladder drug mirabegron exacerbates atherosclerosis through activation of brown fat-mediated lipolysis.

Proceedings of the National Academy of Sciences of the United States of America

2019-05-13

Return to institution outputs